Psilocybin and Compassion: A New Model for Treating Depression
When people read about psilocybin therapy in the news, the headlines tend to focus on the dramatic part: the experience itself. The mystical states. The breakthroughs. The clinical trials showing rapid relief from depression after years of other treatments not quite working.
The headlines aren't wrong. The experiences can be that profound. But there's a quieter question, less covered, that's been increasingly important in the research:
What happens after the experience?
For some people, the answer is real and lasting change. For others, the gains fade within weeks or months. They return to the same patterns — the same self-criticism, the same depression, the same harsh inner voice — that the experience seemed to interrupt. And they're often left more demoralized than before, having glimpsed freedom and lost it.
A growing body of clinical thinking suggests this isn't because psilocybin doesn't work. It's because the experience, on its own, doesn't address one of the most stubborn structures in depressive suffering: the relationship a person has with themselves.
A 2022 paper in Frontiers in Psychiatry proposes a specific solution to this gap: pairing psilocybin therapy with Compassion Focused Therapy, or CFT, an approach developed by clinical psychologist Paul Gilbert that targets the harsh inner voice directly. I want to walk through why this combination matters — because for many of the people I see, the inner critic is the part of suffering that survives every other treatment.
Why Psilocybin Opens Something Few Other Tools Can Reach
Psilocybin, the active compound in psychedelic mushrooms, does something to consciousness that most other therapeutic tools don't.
It temporarily disrupts the brain's default mode network — the system responsible for self-referential thought, narrative, and the felt sense of being a separate self. In ordinary consciousness, this system is mostly running in the background, producing the internal commentary that accompanies most of our waking lives. Under psilocybin, this commentary loosens. The grip of habitual self-perception softens. The story you've been telling about who you are can briefly suspend.
What people experience during this opening varies. Some encounter a deep sense of connection — to themselves, to others, to something larger. Some meet old material — grief, fear, suppressed memories — with a kind of openness that ordinary consciousness wouldn't allow. Some have what they describe as mystical or transformative experiences. Some simply find that the relentless self-monitoring quiets for the first time in years.
Clinical research has shown that even a single dose of psilocybin, in a clinical setting with appropriate support, can produce rapid and sustained reductions in depressive symptoms — in some cases lasting a year or longer. For people whose depression has not fully responded to medications and therapy, this is meaningful.
But this is where the gap appears. Because while the experience can open something profound, the question of what happens next — what the person does with the opening — turns out to matter enormously.
What Often Survives the Experience
In my clinical work, and in the research, one of the most persistent observations is this: even powerful psychedelic experiences often fail to dislodge the harsh inner voice.
The person comes back from a profound session with new insight, new openness, a felt sense of having touched something important. And within weeks, the same critical voice that was there before is back — sometimes quieter at first, but slowly reasserting itself. You're falling behind. You're not doing the work right. You should be further along by now. What's wrong with you that you can't make this stick?
This voice is not the depression itself. It's something more specific: the internalized harshness that many people with chronic depression carry as a kind of baseline. Self-criticism. Shame. The conviction that there is something fundamentally wrong with them. The relentless evaluation of every thought, every feeling, every action against an impossibly demanding internal standard.
For many people with depression, this inner critic is the actual engine of their suffering. The depressive symptoms — low mood, withdrawal, hopelessness — are downstream effects of an inner relationship that has been adversarial for years, often decades.
And here's why this matters for psilocybin therapy: opening the system doesn't automatically rewrite the inner relationship. The system can soften, profound material can emerge, and a person can still come back to a self who relates to them harshly. The container of the inner relationship survives even the most dramatic experiences, unless that container is specifically worked with.
This is where CFT enters the picture.
What Compassion Focused Therapy Actually Is
Compassion Focused Therapy, developed by Paul Gilbert at the University of Derby in the early 2000s, was designed specifically for people who struggle with chronic shame and self-criticism. Gilbert noticed that traditional cognitive therapies — which work with the content of thoughts — often fell short for clients whose problem wasn't really what they were thinking but how they were relating to themselves.
You could correct a thought a thousand times. The voice that delivered the correction would still be harsh. The relationship to oneself remained punishing, even as the surface beliefs changed.
CFT's central insight is that human beings have three core emotional regulation systems, evolved for different functions:
The threat system. Activated by danger, criticism, judgment, social rejection. It produces anxiety, fear, anger, vigilance. It motivates self-protection. In small doses, it's lifesaving. Chronically activated, it produces persistent suffering.
The drive system. Activated by goals, achievement, pleasure-seeking. It produces motivation, excitement, ambition. In modern culture, this system is often hyperdeveloped — people live in chronic striving toward the next achievement.
The soothing system. Activated by safety, connection, care. It produces calm, contentment, the felt sense of being held and accepted. It's regulated by oxytocin and other affiliative neurochemistry. This is the system that allows the nervous system to actually rest.
In healthy regulation, all three systems are functional and can balance each other. In chronic depression and anxiety, the threat and drive systems are typically overactive, while the soothing system is underdeveloped — sometimes severely.
Many people with depression have spent their entire lives without much soothing system activity at all. They've been driven, vigilant, self-critical — but rarely warm with themselves, rarely held, rarely safe in their own care. The system that should produce internal warmth has, in effect, atrophied from lack of use.
CFT's work is to deliberately develop the soothing system. Through specific practices, exercises, imagery, and reflection, the person learns — often slowly, often awkwardly at first — what it actually feels like to meet their own suffering with warmth instead of judgment.
This is not the same as telling yourself to feel better. It's not affirmations. It's the slow biological development of a regulatory system that has been quietly missing.
Why These Two Approaches Fit Together So Well
The pairing of psilocybin and CFT is more than additive. Each addresses a layer of the problem the other can't reach on its own.
Psilocybin opens the system. It temporarily disrupts the rigid patterns of self-perception and emotional reactivity that depression locks people into. It creates an opening in which new experiences become possible — including, for the first time in some cases, the felt experience of acceptance, connection, or warmth toward oneself.
CFT teaches the person what to do with the opening. Once the system has softened, CFT provides the practices, language, and framework for building a new internal relationship. Not just having a momentary glimpse of self-compassion, but developing it into a stable capacity that survives the closing of the opening.
Without CFT, the psilocybin experience can produce real moments of inner warmth that fade as the harsh voice reasserts itself. Without psilocybin, CFT can be effective but often slow — the harsh voice can be remarkably resistant to gentle approaches that don't include the kind of system disruption psilocybin offers.
Together, the two appear to do something neither does alone: the opening and the inner reshaping happen in coordinated phases that reinforce each other.
What This Looks Like in Practice
The 2022 paper outlines a structured protocol that pairs psilocybin sessions with CFT-based preparation and integration.
In the preparation phase, the patient learns about the "tricky brain" — Gilbert's accessible framing of the fact that our brains evolved capacities (self-criticism, threat detection, social comparison) that were useful in ancestral environments but produce significant suffering in modern life. The patient also learns basic compassion practices — soothing breathwork, compassionate imagery, ways of speaking to themselves that they may have never tried before.
This preparation does important work. It gives the patient a framework for understanding what their mind is doing. It introduces practices that may feel foreign or even uncomfortable at first. It begins building the soothing system in advance of the psilocybin session, so there's something to come back to afterward.
The psilocybin session itself is largely non-directive. The patient is supported but not steered. The work of meeting whatever arises is theirs. Often, in this state, the warmth they've been practicing with effort can become available with less resistance — the inner critic loosens enough that compassion can briefly take its place.
The integration phase is where CFT becomes essential. The opening from the session is real but temporary. Whatever was glimpsed has to be deliberately built into ordinary life through practice. Compassionate self-reflection. Imagery work that develops the soothing system. Recognizing the parts of the self that have been suppressed or rejected. Speaking to oneself in the voice one would speak to a loved one.
This work is slow. It's also where lasting change actually happens.
The Deeper Shift
What this model points toward is something I find clinically and personally important.
For a long time, mental health treatment has focused on symptom reduction. The depression scores go down. The anxiety subscale improves. The medications produce measurable changes.
What this approach suggests is something different. It's not really about reducing symptoms. It's about transforming the relationship a person has with their own inner life.
The depression may lift. The anxiety may quiet. But the deeper change — the one that holds — is in how the person meets themselves. Whether their default response to their own suffering is judgment or care. Whether they treat themselves as adversaries or as someone worthy of warmth.
Many people have never had this experience of themselves. They've been their own harshest critic for so long they don't even recognize the harshness as something separate from who they are. The combination of psilocybin's opening and CFT's compassionate scaffolding can, for some, be the first introduction to what an alternative actually feels like.
What's Still Uncertain
This approach is still emerging. The 2022 paper is theoretical and clinical rather than the kind of large randomized controlled trial that would establish it as standard practice. There's a great deal we don't yet know:
How many psilocybin sessions optimize outcomes. How much CFT preparation and integration is necessary. Whether other compassion-focused approaches — Internal Family Systems, mindful self-compassion, ACT-based approaches — work equally well, or whether something specific about CFT fits psilocybin particularly. How outcomes compare to other psychedelic-assisted therapy models.
These are real questions. The clinical trials currently underway in the U.S. and Europe will help answer some of them in the next few years. As psilocybin therapy moves toward potential legalization in various jurisdictions, the question of what to pair it with will become increasingly important.
What seems clear from the existing research and clinical observation is that the answer isn't nothing. The medicine alone, without thoughtful psychological support around it, produces less durable change than the medicine combined with skilled integration. The question is what kind of psychological support best leverages what the medicine offers.
For people whose suffering is significantly shaped by harsh self-criticism — which describes a great many people with chronic depression — CFT or something like it appears to be a particularly powerful match.
A Closing Thought
What I find most hopeful about this model is its underlying premise: that suffering is not a fixed feature of who you are, and that the relationship you have with yourself can change.
For people who have spent decades inside a punishing inner relationship — who have come to assume that this is just how they are — the possibility of relating to themselves differently can be one of the most meaningful discoveries of their lives. Psilocybin may help open the door. The slow, real work of building self-compassion is what makes the new room livable.
If you've found that the standard approaches haven't fully reached the harsh inner voice that drives your suffering, and you're curious about what integrative work could look like for you, you're welcome to book a consultation. Whether or not you ever work with psilocybin or any other medicine, the work of changing your inner relationship is possible — and it can begin now.
